Denali Therapeutics Inc. (DNLI) rose 8.8% or 1.77 to $21.89. It is approximately 378008 shares traded, which is 160.94% compare to the average total volume 234868. The market cap of DNLI is $1.93 billion. The year to date change is 24.74%. The 52 week price range is from $14.72 to $25.79. Price of DNLI have changed -6.72% during last week. It have changed -2.28% over last month, 0.40% over last 3 months, -6.20% over last 6 months and -6.20% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for DNLI is 20.26. It is -7.45% below current price. The 52-week High is 25.79. It is 17.82% from the current price. The 52-week Low is 14.72. It is -32.75% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of DNLI is 16.31 on 2018-02-28. Short % to float is 4.19%. There are some statistics of DNLI. It is has market cap $1.93 billion. The share outstanding is 87.98 million. The average volume is 234868. The percent of top 15 Institution holding is 31.00%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of DNLI is -43.83%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of DNLI is -40.25%.